Evidence map›Paper›PMID 20574894›Full record

ArticleJournal of toxicology and environmental health. Part B, Critical reviews2010

Toxicity testing in the 21st century: a vision and a strategy.

Daniel Krewski, Daniel Acosta, Melvin Andersen, Henry Anderson, John C Bailar, Kim Boekelheide, Robert Brent, Gail Charnley, Vivian G Cheung, Sidney Green and 12 more

Abstract readHistorical Article
In one paragraph

Article in Journal of toxicology and environmental health. Part B, Critical reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 314 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
314citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

314 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review of in vitro approaches for assessing the toxicity of chemical stressors across diverse physiological systems.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Functional Genomics Screening inEnvironmental science & technology · 2026
    Article
  13. Article
  14. Article
  15. Toxicology research · 2026
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Essence of toxicology research to Saudi Arabia Vision 2030 and beyond: Current state and future perspectives.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article

254 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Daniel KrewskiR Samuel McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada. dkrewski@uottawa.ca
Daniel Acosta
Melvin Andersen
Henry Anderson
John C Bailar
Kim Boekelheide
Robert Brent
Gail Charnley
Vivian G Cheung
Sidney Green
Karl T Kelsey
Nancy I Kerkvliet
Abby A Li
Lawrence McCray
Otto Meyer
Reid D Patterson
William Pennie
Robert A Scala
Gina M Solomon
Martin Stephens
James Yager
Lauren Zeise

Funding

Genetics of individual variation in response to radiation exposureR01ES015733 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI CHEUNG, VIVIAN G · 2007 to 2011
$2.3M
NIEHS NIH HHS R01 ES015733
6 · The paper itself

Abstract

With the release of the landmark report Toxicity Testing in the 21st Century: A Vision and a Strategy, the U.S. National Academy of Sciences, in 2007, precipitated a major change in the way toxicity testing is conducted. It envisions increased efficiency in toxicity testing and decreased animal usage by transitioning from current expensive and lengthy in vivo testing with qualitative endpoints to in vitro toxicity pathway assays on human cells or cell lines using robotic high-throughput screening with mechanistic quantitative parameters. Risk assessment in the exposed human population would focus on avoiding significant perturbations in these toxicity pathways. Computational systems biology models would be implemented to determine the dose-response models of perturbations of pathway function. Extrapolation of in vitro results to in vivo human blood and tissue concentrations would be based on pharmacokinetic models for the given exposure condition. This practice would enhance human relevance of test results, and would cover several test agents, compared to traditional toxicological testing strategies. As all the tools that are necessary to implement the vision are currently available or in an advanced stage of development, the key prerequisites to achieving this paradigm shift are a commitment to change in the scientific community, which could be facilitated by a broad discussion of the vision, and obtaining necessary resources to enhance current knowledge of pathway perturbations and pathway assays in humans and to implement computational systems biology models. Implementation of these strategies would result in a new toxicity testing paradigm firmly based on human biology.

Indexed as

AnimalsEnvironmental PollutantsHistory, 20th CenturyHistory, 21st CenturyHumansNational Academy of Sciences, U.S.Risk AssessmentToxicity TestsUnited StatesUnited States Environmental Protection AgencyEnvironmental Pollutants

Identifiers

PMID20574894
PMCPMC4410863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.